1
CARDIOVASCULAR
hamburger

About the CentriMag Acute Circulatory Support System

Excellent hemocompatibility and unparalleled versatility for optimized patient care.

Watch this video to see the CentriMag Pump in action.

play video

CentriMag Pump: Designed for Optimal Hemocompatibility1,2

Driven by Full MagLev™ Flow Technology, the CentriMag™ Pump includes a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.3,4

 

The CentriMag™ System is the only acute circulatory support system approved for 30-day use.*

Addressing the broadest spectrum of clinical challenges

The CentriMag System functions as:

  • Part of a cardiopulmonary circuit for periods up to 6 hours
  • Extracorporeal bypass circuit for periods up to 30 days*, to support the left, right, or both ventricles of the heart

The CentriMag System includes both pediatric and adult pump options, producing flows up to 1.5 LPM for pediatric, and 10 LPM for adult.

Designed to meet individualized requirements

The CentriMag System offers freedom of choice. It fits seamlessly into custom circuit designs, and can be used with a variety of cannulation options.

Front Two Consoles of the CentriMag Acute Circulatory Support System

CentriMag Acute Circulatory Support System

CentriMag Pump for Adults

CentriMag Pump

PediMag Pump for Adults

PediMag Pump

  • Manuals & Technical Resources
  • Cardiovascular Products
  • Customer Service

*PMA approval for 30-day use of CentriMag System components include: CentriMag™ Pump, CentriMag™ Console, CentriMag™ Motor, Mag Monitor, Flow Probe, and CentriMag™ Drainage Cannula and CentriMag™ Return Cannula. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. PMA approval for 30-day use of CentriMag™ System excludes: PediMag™ Blood Pump and any other pediatric components or accessories.
† Approved for 30-day use
†† Cleared for 6-hour use.

References

  1. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085
  2. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046
  3. Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71. http://dx.doi.org/10.1016/j.healun.2009.08.025
  4. Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976. https://www.jhltonline.org/article/S1053-2498(09)00238-1/fulltext
INDICATIONS, SAFETY & WARNINGS

MAT-2006910 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.